From Prototype to Production: How Medical Device Shipping Foam Helps OEMs Reduce Damage Rates

A device that arrives damaged isn’t just a costly return—it’s a compliance event. For medical device OEMs, damage during shipping can trigger complaint investigations, delay regulatory submissions, and erode the hard-won trust of hospital procurement teams. The right medical device shipping foam addresses all three risks before a single unit ships. This article walks through how foam packaging is designed to survive real-world distribution hazards, what standards govern that testing, and where Reilly Foam’s ISO 13485-certified materials fit into a typical OEM workflow from first prototype to full production.

Already know what you need? Request a material sample or talk to our packaging team at reillyfoam.com/contact-us/.

What Medical Device Shipping Foam Actually Has to Survive

Medical devices travel through a punishing distribution chain before they reach clinical use. A single shipment might move through a regional distribution hub, sit in LTL freight with stacked loads, transfer to local delivery, and then get dropped on a loading dock. What does that look like in testing terms?

Under ASTM D4169—the FDA-recognized standard for medical device distribution testing—packages are subjected to sequential drops, compression, vibration, and low-pressure simulation designed to replicate that exact journey. The most commonly selected protocol, Distribution Cycle 13 (DC13), simulates truck and air freight in seven consecutive tests. Packages must maintain sterile barrier integrity through all of them. Passing this validation is a requirement for most 510(k) submissions.

Foam is doing most of the work. It absorbs impact energy on drops, prevents device movement during vibration, and distributes compressive loads from stacked boxes. Generic foam won’t reliably pass. The material selection, density, and geometry have to match the device’s fragility rating and the distribution environment it will face.

Three Design Considerations That Determine Whether Foam Passes or Fails

Impact Energy Absorption

Foam selection for medical device packaging starts with the device’s fragility value—essentially, how much acceleration (measured in Gs) the device can withstand before damage occurs. Engineers then select foam density and thickness to absorb drop energy without transmitting that force to the device. Polyethylene foams, including crosslinked grades like Volara, are frequently chosen for their closed-cell structure, which provides consistent cushioning performance and resists permanent deformation over repeated handling cycles. Polyurethane foams offer more flexibility in density options and are widely used where convoluted (egg-crate) profiles are needed to reduce contact area and improve energy distribution around irregular device geometries.

Sterilization Compatibility

Many foam inserts contact sterile packaging or must survive the same sterilization cycles as the device. Common methods—ethylene oxide (EtO), gamma radiation, and autoclaving—affect foam chemistry differently. Not every foam survives all three. OEMs need material data confirming stability under their specific sterilization method. Reilly Foam supplies foam materials that are compatible with current sterilization processes and provides documentation to support the material qualification phase of your design history file.

Cleanroom and Particulate Requirements

Class II and Class III devices often require packaging components fabricated or processed in controlled environments. Foam that sheds excessive particles can compromise sterile barrier integrity downstream. Closed-cell foams generally produce less particulate than open-cell alternatives, but fabrication method matters too. Precision die cutting and CNC foam cutting—both available from Reilly Foam—produce cleaner edges with less particle generation than hand-cutting or less controlled processes. This is worth specifying early, because switching fabrication methods after packaging validation adds significant time and cost.

Where Foam Enters the OEM Workflow

Foam packaging decisions tend to cluster at three points in a typical OEM product development cycle:

• Design freeze and packaging validation planning. This is when foam geometry and material are specified against the device’s fragility profile and sterilization requirements. Requesting material samples early—before tooling is cut—avoids late-stage substitutions that require revalidation. 
• ASTM D4169 or ISTA 3A validation testing. Material consistency matters here. If the foam used in testing differs from production material—even subtly in density or cure—testing data may not represent commercial units. ISO 13485-certified suppliers like Reilly Foam maintain documented material traceability, which protects the integrity of your test data and simplifies FDA review. 
• Scale-up to production volumes. A foam insert that works at 500 units needs to perform identically at 50,000. That requires a supplier with consistent raw material sourcing, documented process controls, and manufacturing capacity to grow with product demand. Reilly Foam operates across four U.S. locations with over 450,000 square feet of manufacturing space specifically to support that kind of scale. 

What ISO 13485 Certification Actually Means for Your Documentation

ISO 13485 is the quality management standard for medical device manufacturing. It requires audited process consistency, traceable material records, and a quality system structured to produce the documentation OEM teams need for design history files and 510(k) submissions. For packaging engineers, that means a certified foam supplier is already operating inside the compliance framework your submission requires—not catching up to it.

Reilly Foam is ISO 13485:2016 certified across multiple facilities. Supplier qualification is supported by verifiable documentation rather than anecdotal assurances. It also means the material you validated is the material you receive in production—a distinction that matters when your packaging is part of a regulatory submission.

Foam Materials That Fit Medical Device Packaging Applications

Reilly Foam supplies several foam types commonly specified in medical device packaging. Crosslinked polyethylene (Volara) offers a closed-cell structure that performs well in impact-critical inserts for diagnostics and surgical instruments. Polyurethane foams provide density flexibility for custom die-cut profiles that secure devices within secondary packaging. For applications requiring fluid management—such as single-use device trays where condensation control matters—Aquazone hydrophilic foam provides controlled absorbency without compromising structural support.

All foam materials available through Reilly Foam can be processed using precision die cutting, CNC foam cutting, or convoluting to produce the exact geometry your packaging design requires. Adhesive lamination is also available for applications requiring foam-to-film or foam-to-tray bonding.

Your Validation Timeline Doesn’t Have Room for the Wrong Supplier

Packaging validation failures don’t just cost money—they cost months. A foam material that fails ASTM D4169 testing, sheds particles into a sterile barrier, or can’t be sourced consistently through production means repeating work your timeline can’t absorb.

Reilly Foam has been supplying ISO 13485-certified foam materials to the medical device industry for over 40 years. We provide material samples, fabrication documentation, and technical support at every stage of your packaging program—from the first prototype insert through full commercial production.

Contact us today to discuss your packaging requirements and request material samples: reillyfoam.com/contact-us/ or call our main office directly at (610) 834-1900. Reach out to get started.